Get started
Author

Juliane Wilhelmine Schott

Observed names: J Schott, J W Schott, Juliane Schott, Juliane W Schott, Juliane W. Schott, Schott, Juliane, Schott, Juliane W.
ORCID: 0009-0007-9583-6757
Observed ORCID: 0009-0007-9583-6757
OpenAlex ID: A5089830895
Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections
2018 · Mania Ackermann, Henning Kempf, et al. · Nature Communications · 165
PDF
Viral and Synthetic RNA Vector Technologies and Applications
2016 · Juliane W Schott, Michael Morgan, et al. · Molecular Therapy · 76
PDF
Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells
2017 · D Hoffmann, J W Schott, et al. · Gene Therapy · 57
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
2012 · Barbara Kropff, Christiane Burkhardt, et al. · PLoS Pathogens · 52
PDF
Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning
2021 · Adrian Schwarzer, Steven R. Talbot, et al. · Molecular Therapy · 50
PDF
Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem Cells for Clinical Application
2019 · Juliane W. Schott, Diego León-Rico, et al. · Molecular Therapy — Methods & Clinical Development · 50
PDF
Viral and Non-Viral Approaches for Transient Delivery of mRNA and Proteins
2011 · Juliane W. Schott, Melanie Galla, et al. · Current Gene Therapy · 40
Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseudogenes
2019 · Denise Klatt, Erica Cheng, et al. · Stem Cell Reports · 28
PDF
Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1B
2023 · Juliane W. Schott, Peixin Huang, et al. · Molecular Therapy · 25
Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells
2017 · Franziska K. Geis, Melanie Galla, et al. · Retrovirology · 18
PDF
Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants
2021 · Julia Dahlke, Juliane W. Schott, et al. · Journal of Personalized Medicine · 17
PDF
Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis
2017 · Luca Biasco, Michael Rothe, et al. · Hematology/Oncology Clinics of North America · 17
Improved retroviral episome transfer of transcription factors enables sustained cell fate modification
2014 · J W Schott, D Hoffmann, et al. · Gene Therapy · 12
Retrovirus-based vectors for transient and permanent cell modification
2015 · Juliane W Schott, Dirk Hoffmann, et al. · Current Opinion in Pharmacology · 11
Protection from cisplatin-induced hearing loss with lentiviral vector-mediated ectopic expression of the anti-apoptotic protein BCL-XL
2024 · Larissa Nassauer, Hinrich Staecker, et al. · Molecular Therapy — Nucleic Acids · 8
The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells
2024 · Larissa Nassauer, Juliane W. Schott, et al. · Journal of Molecular Medicine · 7
PDF
An immune cell spray (ICS) formulation allows for the delivery of functional monocyte/macrophages
2018 · Valerie Beneke, Fennja Küster, et al. · Scientific Reports · 7
PDF
Gene therapy as a possible option to treat hereditary hearing loss
2020 · Michael Morgan, Juliane W. Schott, et al. · Medizinische Genetik · 6
PDF
Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration‐deficient retroviral vectors
2015 · Juliane W. Schott, Nico M. Jaeschke, et al. · Cytometry Part A · 5
PDF
Uncoupling the Oncogenic Engine
2017 · Axel Schambach, Juliane W. Schott, et al. · Cancer Research · 2
Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells
2017 · Franziska K. Geis, Melanie Galla, et al. · Retrovirology · 2
PDF
Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice
2026 · Jennifer Marx, Peixin Huang, et al. · Molecular Therapy Advances · 1
Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors
2026 · Felix L. Warnecke, Moritz Ertelt, et al. · Human Gene Therapy
Sound effects: paradigm gene therapy approach installs hearing in children and adolescents born deaf
2026 · Juliane W. Schott, Michael Morgan, et al. · Signal Transduction and Targeted Therapy
PDF
Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1BThird-generation lentiviral gene therapy rescues function in a mouse model of Usher 1B
2023 · Athanasia Warnecke, Juliane Schott, et al. · Laryngo-Rhino-Otologie
Works count: 30
Citation count: 656
H-index: 12
I10-index: 14
Year
Topic
Type